Previous close | 138.50 |
Open | 138.70 |
Bid | 139.08 x 100 |
Ask | 139.33 x 100 |
Day's range | 138.70 - 139.92 |
52-week range | 110.74 - 159.52 |
Volume | |
Avg. volume | 99,998 |
Market cap | 4.493B |
Beta (5Y monthly) | 0.70 |
PE ratio (TTM) | 41.45 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.79 (0.57%) |
Ex-dividend date | 26 Dec 2023 |
1y target est | N/A |
MONTVALE, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today published its 2023 Sustainability Report, highlighting the Company's Corporate Social Responsibility initiatives and accomplishments. Guided by our core values and our vision of making the world a healthier place, our Sustainability Report demonstrates the Company's continuing promise to provide our employees, customers, shareholders and the communities within which we operate with information on Balchem’
MONTVALE, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, May 3, 2024, at 11:00 AM Eastern Time (ET) to review first quarter results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. First quarter results will be published prior to the market opening on Friday, May 3, 2024. The press release, and its accompanying financial exhibits, will also be available
MONTVALE, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate at the BNP Paribas Exane 12th Consumer Ingredients Conference on March 14, 2024. Ted Harris, Chairman of the Board, Chief Executive Officer, and President, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations will participate at the conference. More inform